Mesoporous carbon with graphitic pore walls is highly desired in many electrochemical applications such as fuel cells and lithium ion batteries. In this study, ordered graphitic mesoporous carbon was prepared by chemical vapor deposition (CVD) of benzene in the pores of mesoporous SBA-15 pure-silica template without loading any catalytic species. Nitrogen adsorption, small-angle X-ray scattering, X-ray diffraction, Raman spectrometry, field-emission scanning electron microscopy, transmission electron microscopy, and thermogravimetric analysis techniques were used to characterize the samples. It was observed that the CVD method affords highly ordered mesoporous carbon with graphitic pore walls and low carbon shrinkage because of the high degree of infiltration of pyrolytic carbon. The catalytic performance of the mesoporous carbon as a support for Pt catalyst in room-temperature methanol oxidation was examined. Results show that the specific activity of the Pt catalyst supported on the mesoporous carbon is higher than that of a commercial Pt catalyst form E-TEK.

Lichens play significant roles in ecosystem function and comprise about 20% of all known fungi. Polyketide-derived natural products accumulate in the cortical and medullary layers of lichen thalli, some of which play key roles in protection from biotic and abiotic stresses (e.g., herbivore attacks and UV irradiation).

Bioprobes are indispensable tools for biological study and clinical diagnosis. A conventional strategy for probe development is hypothesis-driven approach based on known molecular mechanisms of recognition for individual analytes. However, even the most sophisticated rational design does not always guarantee the applicability of probes in complex biological systems, therefore the efficiency and scope of probe development has been intrinsically limited. Diversity-driven approach is a rapidly emerging alternative and has been employed for the development of new probes even in the absence of the knowledge about target recognition mechanism. This tutorial review summarizes the recent advances in probe development along with conceptual advantages and perspectives of the diversity-driven approach.

No abstract

Tumor initiating cells (TIC) are resistant to conventional anticancer therapy and associated with metastasis and relapse in cancer. Although various TIC markers and their antibodies have been proposed, it is limited to the use of antibodies for in vivo imaging or treatment of TIC. In this study, we discovered heme oxygenase 2 (HMOX2) as a novel biomarker for TIC and developed a selective small molecule probe TiNIR (tumor initiating cell probe with near infrared). TiNIR detects and enriches the functionally active TIC in human lung tumors, and through the photoacoustic property, TiNIR also visualizes lung TIC in the patient-derived xenograft (PDX) model. Furthermore, we demonstrate that TiNIR inhibits tumor growth by blocking the function of HMOX2, resulting in significantly increased survival rates of the cancer model mice. The novel therapeutic target HMOX2 and its fluorescent ligand TiNIR will open a new path for the molecular level of lung TIC diagnosis and treatment.